Recurrent stress across life may improve cognitive performance in individual rats, suggesting the induction of resilience by Hadar, Ravit et al.
Hadar et al. Translational Psychiatry           (2019) 9:185 
https://doi.org/10.1038/s41398-019-0523-5 Translational Psychiatry
ART ICLE Open Ac ce s s
Recurrent stress across life may improve
cognitive performance in individual rats,
suggesting the induction of resilience
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Abstract
Depressive symptoms are often accompanied by cognitive impairments and recurrent depressive episodes are
discussed as a potential risk for dementia. Especially, stressful life events are considered a potent risk factor for
depression. Here, we induced recurrent stress-induced depressive episodes over the life span of rats, followed by
cognitive assessment in the symptom-free period. Rats exposed to stress-induced depressive episodes learned faster
than control rats. A high degree of stress-induced depressive-like behavior early in the paradigm was a predictor of
improved cognitive performance, suggesting induction of resilience. Subsequently, exposure to lorazepam prior to
stress-induced depressive episodes and cognitive testing in a nonaversive environment prevented the positive effect.
This indicates a beneﬁcial effect of the stress-associated situation, with the existence of individual coping abilities.
Altogether, stress may in some have a beneﬁcial effect, yet for those individuals unable to tackle these aversive events,
consecutive unpleasant episodes may lead to worse cognitive performance later in life.
Introduction
A history of recurrent depression episodes has been
suggested to constitute a risk factor for dementia, such
that vulnerability toward dementia has been correlated to
the frequency of the depressive episodes, with recurrent
episodes increasing the risk1. In the clinic, cognitive
complaints are often reported by depressed patients
during the symptomatic, and also the remitted phase and
depression has been suggested as an early manifestation of
dementia1,2. What remains to be investigated is whether
and how experiencing depressive episodes inﬂuence
cognitive performance later in life, long after symptoms
have subsided and thus no direct interaction and overlap
are evident.
The experience of being unable to avoid or handle
stressful life events is considered a potent risk factor for
depression3–7, and is implemented in the learned help-
lessness (LH) paradigm that induces a transient, depressive
phenotype in rodents8. On a behavioral level, the experi-
ence of unescapable stress induces helplessness and sub-
sequent anhedonia-like behavior in the animal, whereas on
a neurobiological-level serotonergic dysregulation,
decrease in brain-derived neurotrophic factor (BDNF)
levels and hippocampal deﬁcits become evident9–12. The
LH paradigm relies on the observation that the response a
stressor elicits in an animal is dependent upon its cogni-
tive appraisal3. Clinical ﬁndings also suggest that the
manifestation of depression following an adverse life event
depends on the situation, as well as the individual sub-
jected to it13. To this end, the controllability of the aver-
sive situation is a critical factor that determines the
induction of a depressive phenotype14–16. Previously,
studies have shown that exposure to stress in the LH
paradigm reduces cognitive performance in some
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individuals when subjects are tested for the acquisition of
an escape response after 24 h17.
The course of depression varies between individuals, yet
the majority of patients experience recurrence following
recovery, with the probability of recurrence increasing
with every subsequent episode. On a neurobiological level,
recurrent stress-induced depression has been shown to
induce hippocampal damage as well as alterations in
neurogenesis and long-term potentiation, that may be
accountable for the frequent cognitive dysfunctions seen
in depression4,5,18. However, there is no direct evidence
that these alterations indeed persist and thus affect cog-
nitive performance later in life. As such, investigation into
how cognitive functions are altered following stress-
induced depressive episodes on a life-long trajectory is
needed. Given the increase in life expectancy worldwide,
insight into the link between recurrent stress-induced
depression and cognitive performance is of major
importance, as for most a causation between recurrent
depression and declined cognitive performance would
point to the necessity of adequate early treatment for
depression. Thus, the aim of this study was to investigate
the impact of recurrent, transient stress-induced depres-
sive symptoms on cognitive performance, when induced
across the life span of an aging rat.
Materials and methods
Animals and housing
Male Sprague–Dawley rats (8 months of age) (n= 78)
were used. Animals were housed in a temperature and
humidity-controlled vivarium with a 12 h light–dark cycle
with food and water ad libitum. All experiments were in
accordance with the German Animal Welfare Act and
approved by the Landesdirektion Sachsen (24-9168.11-1/
2013-63).
Experimental design
In a ﬁrst set of experiments (n= 33), animals were
randomly divided into a control group (n= 14) and an
intervention group (n= 19), after which they were fol-
lowed across a life span for about 10 months. The inter-
vention group was subjected to controlled, transient
recurrent depressive (rd) states through the LH paradigm.
In addition, the LH paradigm was also used to measure
the degree of helplessness present in the individual ani-
mal3,19. Induction and transiency of depressiveness were
assessed through the sucrose consumption test (SCT)
which was conducted prior to each LH test session to
prove transiency, as well as after the ﬁnal LH test to verify
induction. The SCT was chosen, as it constitutes a stress-
free paradigm and thus can be employed to investigate the
degree of depressiveness without interfering with symp-
tom presentation. Cognitive performance was later
assessed using the Morris water maze (WM). The WM
was conducted 6–8 weeks after the last LH test, to prevent
the induced stress and depressiveness from having a
direct known impact on performance20. Control rats went
through the same consecutive SCT paradigm, yet did not
undergo actual LH testing as they were only placed in the
LH conditioning chambers (Fig. 1a). To further assess the
impact of the stress mediated by the LH paradigm on
cognitive performance, an additional test round was
conducted on (n= 45). Rats (n= 26; 16 controls and 10
rd) were subjected to lorazepam (i.p. 0.3 mg/kg body
weight) 30 min prior each LH paradigm and subsequently
tested in the WM (Fig. 2a). Rats serving as controls (n=
19) received saline injection and underwent the same
treatment as above (11 control and 8 rd). In this experi-
ment, all rats were also tested in the radial maze (RM)
(Fig. 3a). One week following the last LH test, rats started
receiving i.p. injections (50 mg/kg body weight) of BrdU
(Sigma-Aldrich, Germany, 0.9% saline) three times/day
for 3 days. Following the cognitive paradigm(s), neuro-
biological investigations were conducted (Fig. 3a).
Behavioral assessment
Learned helplessness (LH): In this study, we employed
a well-validated protocol for LH17. The setup consisted of
an Operant Behavior System Mannheim Type 259900
(TSE, Bad Homburg, Germany) that included an operant
conditioning chamber (48.5 × 30 × 21.5 cm) and a shock
generator. The LH paradigm took place over two con-
secutive days. At day 1 (conditioning phase), rats were
exposed to an unpredictable, inescapable shock situation
for 40min (200 ms phase duration; intensity of 0.8 mA).
Shocks lasted between 5 and 15 s, with an inter-trial time
of 5–15 s, leading to a total shock time of 20min/test. On
the consecutive day (test phase), animals were placed in
the same conditioning chamber, now including a lever
(3.5 × 3.5 cm) and signal light (white, 12W, 4 cm above
the lever). Each shock was indicated by a light clue, and
could be terminated through lever press. During the
testing phase, animals received 15 shocks of maximum
60 s in duration (inter-trial time: 24 s). Latency to escape
the shock (seconds) was calculated for each animal.
Sucrose consumption test (SCT): The SCT was
employed to measure depressiveness21. Two days prior to
testing, animals were habituated to testing bottles con-
taining water for 30 min. Twenty-four hours prior to
testing, animals were habituated to the sweetened con-
densed milk (Milchmädchen 1:3) for 30min and food
restricted (15 g chow per rat). On testing day, animals
were presented with two bottles containing either tap
water or sucrose solution for 15min. Bottles were
weighed before and after testing. Sucrose consumption
(ml) was calculated relative to body weight. Water Maze
(WM): The WM was used to assess cognitive perfor-
mance22. The test apparatus consisted of a water-ﬁlled
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(35 cm depth; 22 °C), circular pool (Ø 1,60 m, height:
76 cm) with a submerged (2 cm underwater) hidden
platform (15 cm × 15 cm). Visual cues were provided
around the pool. Each animal was tested for four trials/
day over four consecutive days (60 s acquisition trials,
with a retention time on the platform for 5 s). In the ﬁrst
trial, the animal was dropped from the farther quadrant
from the platform, and for the next trials from the suc-
cessive quadrants following a clockwise order. If the ani-
mal did not ﬁnd the platform, then it was guided to it and
left sitting for 5 s. Swim paths were recorded via Etho-
Vision Pro 3.1 (Noldus) and latency to ﬁnd the platform
(in seconds) was assessed. Learning was calculated as the
time difference (in seconds) to ﬁnd the platform between
the 1st and 4th test. Radial Arm Maze (RAM): Animals
were food restricted two days prior to testing (20 g chow
per rat) and monitored so that there was not a weight loss
of more than 20%. The gray plexiglas RAM consisted of
an octagonal central platform (47 cm in diameter) ele-
vated 65 cm above the ﬂoor, with eight arms (40 cm ×
15 cm) radiating from the platform at equal angles, all
surrounded by 25 -cm height walls. At the end of each
arm, there was a well where the bait was placed. For
testing, rats were placed in the center of the RAM. From
testing days 1–3, animals freely explored the maze for
10min or until bait placed in each of the eight arms was
consumed. On days 4–8, bait was randomly assigned to
four arms doors were closed while placing the rat in the
central platform, then opened at the same time and when
a rat entered an arm with the whole body it was con-
sidered the chosen arm and the doors of the other arms
were closed; after eating the bait, the animals were
Fig. 1 The induction of depressiveness. a Experimental design showing the time-points of measurement and induction of recurrent depressive
episodes over the life span of an ageing rat. b Latency to escape the shock in the LH paradigm and sucrose consumption in the SCT measured over
course of the study. c Correlation between performance in the LH and SCT. d Average body weight in gram over the course of the study.
e Correlation between latency to escape the shock and body weight in gram. f Serotonin levels in various cortical and subcortical areas. LH learned
helplessness paradigm, SCT sucrose consumption test, BW body weight, WM water maze, rd recurrent depression, mPFC medial prefrontal cortex,
OFC orbitofrontal cortex, DM dorsal medial thalamus, Hipp hippocampus, Nacc nucleus accumbens, CPu caudate putamen, Raphe raphe nucleus.
Where applicable, the data are provided either as individual data points or given as mean SEM. Asterisk (*) indicates signiﬁcant differences between
treatment groups
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allowed to return to the central platform, the doors were
closed again and after a delay of 5 s the doors were open
again. Animals explored for 10min or until all the bait
was consumed. The number of correctly entered (baited)
arms was annotated, and reference (entry into non-baited
arm) and working memory (entry into previously visited
arm) was assessed23.
Post mortem neurobiological assessment
Each half of the rats were either transcardially perfused
or decapitated following ﬁnalization of the WM/RM.
After transcardial perfusion, coronal sections of 40 µm for
histology and 1mm for content measurements were cut
on a cryostate. After decapitation, brains were extracted
and snap-frozen in liquid nitrogen. Bromodeoxyuridine
(BrdU) assessment: Prepared slices were stained with
primary (1:500, rat anti BrdU, AbED Serotec) and sec-
ondary antibodies (1:500, donkey anti rat, Dianova). The
number of BrdU-positive cells were counted from one-in-
6 series of sections (240 μm apart) in the hippocampus
(Hipp). BDNF measurement: Hippocampal samples were
obtained by extracting the whole hippocampus out of
three 1- mm slices at bregma level −2.3 to −5.3 according
to Paxinos & Watson’s brain atlas. Samples were homo-
genized by ultrasonication for 20 s in 0.7 ml of extraction
buffer containing 100mM Tris-HCl, 400mM NaCl, 0.1%
NaN3, and stored at −80 °C until use. Endogenous hip-
pocampal BDNF concentrations were measured in the
rethawed homogenates using commercial ELISA kits in
principle according to the manufacturer’s instructions
(Promega), but adapted to a highly sensitive ﬂuorometric
technique as described in detail elsewhere24. BDNF con-
tent was expressed as equivalents of recombinant human
BDNF. The detection limit of the assay was 1 pg/ml.
Determinations of recovery and speciﬁc and nonspeciﬁc
neurotrophin binding (the latter against mouse IgG1
obtained from MOPC 21) involved triplicate ﬂuorescence
determinations for each tissue sample. Using this
improved ﬂuorometric ELISA, it was feasible to quantify
BDNF in brain tissue with a minimal wet weight of
~5 pg24. BDNF levels were expressed as picograms per
milligram of tissue (wet weight) OR:? g of protein? High-
performance liquid chromatography (HPLC): Tissue
samples were obtained via micropunches of Ø 1mm from
the left medial prefrontal cortex (mPFC, the cingulate
cortex area 1, pre- and infralimbic cortex taken together
at Bregma level 3.2–2.2, left orbitofrontal cortex (OFC,
ventrolateral and lateral part, Bregma 3.2–2.2.), dorsal
medial thalamus from both hemispheres (DM, −3.3 to
−4.3), left nucleus accumbens (Nacc, 1.7–0.7), left cau-
date putamen (CPu, 1.7–0.7), and central raphe nucleus
(raphe, −7.3 to −8.3). Samples were homogenized
immediately by ultrasonication in 250–750 µl 0.1M per-
chloric acid at 4 °C. In all, 100 µl of each homogenate was
stored at −80 °C for subsequent protein determination.
The homogenates were centrifuged at 17.000 g and 4 °C
for 10min. Serotonin levels (µM/g protein) were mea-
sured in the supernatants via HPLC electrochemical
detection.
Statistics
Behavioral (LH, SCT, WM and RM) and neurobiolo-
gical (BrdU+, BDNF and serotonin levels) analyses were
carried out using a two-way analysis of variance
(ANOVA), with testing group and treatment/test days
as variables. If applicable, a Holm-sidak post hoc test
Fig. 2 The impact of recurrent depression on cognition. a Latency to ﬁnd the platform in the WM. Performance in the LH paradigm over four
consecutive testing days, with the individual four trials presented for the 1st day of testing. b Correlation between learning in the WM and
performance in the ﬁrst LH test (LH1). c Correlation between performance in the SCT and learning in the WM. rd recurrent depression, LH learned
helplessness, WM Water Maze. Where applicable, the data are provided either as individual data points or given as mean SEM. Asterisk (*) indicates
signiﬁcant differences between treatment groups
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was performed for multiple comparisons. A two-sample
t test was applied to assess differences between testing
groups. Correlation analyses was performed to assess
the association between variables. Signiﬁcance was set
to p < 0.05.
Results
The induction of transient, depressive episodes by the
learned helplessness paradigm
Recurrent depressive episodes were induced through
the LH paradigm. Depressiveness was calculated by
Fig. 3 Alleviating the stress and depressiveness. a The experimental design showing the time-points for measurement and induction of recurrent
depressive episodes alongside administration of lorazepam over the life span of an ageing rat. b Learning abilities in the WM for rd and control rats
injected with either saline or lorazepam. c Errors in reference and working memory at testing day 1 and 2 in the RM (d) serotonin levels in the CPu
and raphe in rd and control rats injected either with saline or lorazepam (e) hippocampal levels of BDNF (f) mean number of BrdU+cells. WM water
maze, RM paradigm radial maze, WM1/2 working memory test day 1 and 2, RM1/2 reference memory test day 1 and 2, rd recurrent depression, CPu
caudate putamen, Raphe raphe nucleus. Where applicable, the data are provided either as individual data points or given as mean SEM. Paragraphs
(§) indicate group effects. Asterisk (*) indicates signiﬁcant differences between treatment groups
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latency to escape the shock in the LH paradigm, sucrose
consumption in the SCT test, body weight, and neuro-
biological alterations via serotonin content. Latency to
escape the shock in the LH paradigm showed that the
degree of induced helplessness was stable across con-
secutive trials. Following LH testing (as shown for the last
LH test), rats exposed to recurrent depression (rd-rats)
consumed signiﬁcantly less sucrose solution as compared
with control rats (F(1,30)= 8.275, p= 0.007) (Fig. 1b).
Further assessment indicated a negative correlation
between a decrease in sucrose consumption and latency
to escape to shock in the last LH test (R=−0.412, p=
0.0799) (Fig. 1c). However, this was not evident when
assessing sucrose consumption prior to the consecutive
LH testing episodes, showing that the prior induced
helplessness was transient in nature. Comparing weight
gain between the two groups over the experimental
course using a two-way ANOVA, showed a signiﬁcant
effect for the factor testing group (F(1,291)= 5.087, p=
0.030) and test session (F(8,291)= 127.205, p < 0.001) as
well as signiﬁcant interaction (F(8,298)= 2.014, p=
0.045), with a further post hoc test indicating that rd-rats
generally exhibit lower body weight as compared to
control rats (Fig. 1d). Further investigations indicated that
a decrease in body weight was negatively correlated with
the latency to escape the shock in the last LH test (R=
−0.439, p= 0.0600) (Fig. 1e). Neurobiological assessment
of serotonin content revealed that rd-rats showed an
increase in the raphe nucleus (t(30)=−2.193, p= 0.036)
and a decrease in the CPu as compared with controls (t
(31)= 3.192, p= 0.003) (Fig. 1f).
The effect of recurrent depressive episodes on cognitive
performance
The impact on cognitive performance was assessed in
the WM paradigm. Here, a two-way ANOVA showed a
signiﬁcant effect for the factor testing group (F(1,90)=
6.239, p= 0.018) and testing days (F(3,90)= 36.614, p <
0.001), with rd-rats generally exhibiting shorter latencies
to ﬁnd the platform as compared with controls. Com-
paring the two testing groups for performance on the ﬁrst
testing day in the WM paradigm revealed no signiﬁcant
difference (t(30)= 0.135, p= 0.894) (Fig. 2a). In addition,
investigation into body weight on WM performance
found no correlation between body weight and learning
abilities in the WM (data not shown).
Interestingly, there was an indication of a positive cor-
relation between LH performance in the ﬁrst LH test and
learning abilities in the WM (t(18)= 0.437, p= 0.0701)
(Fig. 2b). In rd-rats, learning did not seem to be associated
to the hedonic state (t(19)=−0.00860, p= 0.972),
whereas in controls a positive correlation was found
between the hedonic state and learning (t(14)= 0.633,
p= 0.0151) (Fig. 2c).
The impact of lorazepam on recurrent depression,
cognitive performance, and neurobiological properties
In a two-way ANOVA, a signiﬁcant interaction was
found on performance in the WM following lorazepam
(F(1,78)= 4.458, p= 0.038), showing that rd-rats receiv-
ing lorazepam did not have improved learning abilities in
the WM (Fig. 3b).
Regarding serotonin levels in the raphe nucleus, a two-
way ANOVA found a signiﬁcant effect for the factor
treatment (F(1,46)= 9.263, p= 0.004), and a signiﬁcant
interaction (F(1,46)= 4.591, p= 0.037), with a further
post hoc test showing that lorazepam normalized ser-
otonin levels in the rd-rats without affecting the controls
rats. A two-way ANOVA found a signiﬁcant interaction
(F(1,47)= 12.085, p= 0.001) in the CPu with post hoc
tests indicating an increase in serotonin levels in the rd-
rats receiving lorazepam, yet a decrease in serotonin levels
in the control rats (p < 0.05) and (p < 0.05). When testing
the effect of lorazepam on hippocampal BDNF, a two-way
ANOVA showed a signiﬁcant effect for the factor phe-
notype (F(1,43)= 13.677, p < 0.001) and treatment (F
(1,43)= 9.681, p= 0.003), as well as a signiﬁcant inter-
action (F(1,43)= 6.465, p= 0.015). Subsequent post hoc
test revealed a signiﬁcant increase in hippocampal BDNF
in the control rats that received lorazepam (p < 0.05) (Fig.
3e). In correlation, a two-way ANOVA of the
effect of lorazepam on BrDu+cells showed a signiﬁcant
interaction (F(1,78)= 4.458, p= 0.038), with a post hoc
test revealing an increase in BrDU+cells in the
control–lorazepam rats (p < 0.05) (Fig. 3f).
The impact of nonaversive environment on cognitive
performance
For both working and reference memory, a two-way
ANOVA found a signiﬁcant effect for testing days
(working memory: F(1,41)= 4.189, 0.047; reference
memory: F(1,41)= 5.525, p= 0.024). For both types of
memory, no signiﬁcant effect was found for the factor
testing group or interaction (Fig. 3c).
Discussion
The aim of this study was to investigate the impact of
recurrent stress-induced depression on later cognitive
performance. The results show that a history of stress-
induced episodes may enhance future learning under
stressful conditions, whereas it was not affecting stress-
free learning paradigms. In the individual animal, the level
of stress experience and depressive-like behavior measured
during the ﬁrst LH episode served as a predictor of the
later performance in the cognitive tasks. The results point
toward the development of individual coping abilities, for
which stress may have a positive impact on cognition.
The induction of depressive-like behavior following LH
was evident as rd-rats consumed signiﬁcantly less sucrose
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than control rats directly following the ﬁnal LH test.
Depressive-like behavior was also reﬂected in a decrease
in body weight of the rd-rats, as well as upregulated ser-
otonin levels as compared with the control rats. These
ﬁndings have been previously associated with depressive-
like behavior in different animal models9,25–27. The cor-
relation between increased serotonin levels and depressive
behavior needs to be further investigated. Consumption of
sucrose was negatively correlated with the latency to
escape the shock, indicating a higher degree of depressive-
like behavior in correlation with impaired performance in
the LH paradigm
Later assessment of cognitive performance in the
symptom-free period showed that rd-rats learned faster
than control rats. This was observed in the WM, with the
rd-rats displaying a shorter latency to ﬁnd the platform
compared with control rats over consecutive trials. To
investigate for confounders, performance in the individual
trials at the ﬁrst testing day of the WM was assessed.
Here, rd and control rats performed equivalently, indi-
cating no difference between the two groups at baseline.
Further assessment of possible confounders found no
correlation between body weight and performance in the
WM (data not shown), thus ruling out the impact of body
weight on learning in the WM.
However, what seemed to inﬂuence the later cognitive
performance was the initial severity of symptoms, as high
degree of depressive symptom presentation in the ﬁrst LH
testing episode predicted improved learning later in the
WM. Surprisingly, this suggests that early depressive
episodes may have had a beneﬁcial effect on later cogni-
tive performance in aging rats. In contrast, the hedonic
state that in control rats was positively correlated with
WM performance, yet this did not have any effect on
learning abilities in rd-rats. This might suggest that the
clinical observation of an association between improved
learning and positive emotions could be abrogated under
certain conditions28.
These ﬁndings raise the question as to whether we have
indeed modeled the inﬂuence of depression on cognitive
performance or rather the impact of resilience?. As such,
it may be that the experience of the early aversive LH
paradigm has helped the animal to better overcome the
later learning task in the also aversive WM, by transfer-
ring knowledge from a previous stressful situation to
another later stressful event. Indeed, other studies have
investigated the correlation between individual resilience
and the ability to control stress. Animal studies have
found that controllable stress exposure may improve
mood and cognitive abilities, which has been linked to an
increase in resilience16,29–31. Others have found that
enhanced learning abilities in rats indicate emotional
controllability, which further was linked to gaining resi-
lience30. Several studies have shown that the effect of
stress on hippocampus-dependent learning, follows an
inverted U-shape, in which too low/high stress levels
impairs consolidation, whereas moderate stress levels is a
prerequisite for long-term memory32–40. Fast arrival to
the platform in the WM paradigm, as a result of stress,
has mainly been observed in animal models, in which
speciﬁc neurotransmitter systems have been modu-
lated32,36,41. Collectively, these studies show that certain
neurotransmitter systems broaden the span of attention
during stressful condition, in which especially corticos-
terone plays a facilitating role, as altered corticosterone
increases memory storage under stressful conditions. As
such, these studies show that an increase in stress levels
facilitates neurobiological modulations that leads to better
performance in later stressful environments32,36,41. As
such, stress exposure may in some individuals lead to the
development of coping strategies that subsequently
moderates the impact of a following stressful challenge
and improves adjustment to future stressful settings31,42.
Given that we studied resilience in stress-associated
situations, one would expect (i) no improvement in cog-
nitive performance if the aversive component from the
LH was removed and (ii) no improvement in cognitive
performance when assessed in a later nonaversive learning
paradigm. To investigate this, we (i) subjected rats to
lorazepam directly prior to LH testing, to normalize the
aversion induced by the paradigm and (ii) integrated the
radial maze to assess learning abilities in a nonaversive
environment.
In accordance with our hypothesis, only rats that had
been subjected to the aversive LH had better cognitive
performance in the WM. Rats injected with lorazepam
performed equivalent to control rats. Yet, by removing the
stress, we also removed the helplessness for which the
experience of a stressor is mandatory. As a result, there no
longer was a deregulation of serotonin in the rd-rats after
receiving lorazepam, i.e., rats did not display the neuro-
biological surrogate of depressiveness and consequently
no depressive-like behavior25. Thus, the question still
remains as to whether it is the continuous depressive
episodes or rather the stress that impacts cognition later
in life. Furthermore, the intensity of recurrent stress epi-
sodes tends to variate across a patient’s life span, therefore
in order to more accurately mimic the clinical situation,
the effect of ﬂuctuating stress levels on coping abilities
should be investigated in future studies.
Subsequently, we checked for resilience-associated
parameters, such as BrdU cells and BDNF levels, and
found an increase of these parameters upon lorazepam
administration in controls. Hippocampal BrdU expression
and BDNF levels following stress exposure have shown to
be regulated in a temporal age-dependent manner, which
previously have led to discrepancy when wanting to
understand the neurobiological impact of stress on these
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parameters43. The fact that resilience associated para-
meters are not affected in the rd-rats may support this
notion, as the results only reﬂect the last LH testing epi-
sode. However, interestingly we have two different
antagonizing effects in controls and rd-rats, suggesting
that it is the pathology/vulnerability of the brain that
directs the impact of factors that modiﬁes stress.
Learning in the nonaversive RM paradigm, did not
differ between rd and control rats in either working or
reference memory, showing that improved learning is
only found in stress-associated situations. In correlation,
studies have shown that especially stress has a differential
neurobiological and thus behavioral effect, depending on
how the stressor is perceived. Chronic, unpredictable
stress induces a decline in hippocampal neurogenesis and
through this impairs hippocampal-dependent cogni-
tion5,44–46. In contrast, mild-to-moderate predictable
stressors increase hippocampal neurogenesis, improves
cognition and resilience16,29,43. Given the differential
response observed between the rats in the WM paradigm,
our ﬁndings indicate that the experience of the stressor
induced by the LH paradigm may indeed vary between the
individual animals as well as have a varying impact on
coping abilities over time. The exact reason why some
individuals learn to cope, while others fail to do so fol-
lowing the same type of stressor, still needs to be
explored. Further studies are also needed to access whe-
ther the indication of resilience as seen in the WM
paradigm, is a consequence of increased attention,
improved performance strategies or other.
The differential ﬁndings indicate the presence of indi-
vidual resilience and the development of coping strategies
following the exposure to an aversive situation. Here,
ﬁndings point toward a stress-mediated response. Alto-
gether, stress may in some have a beneﬁcial effect, yet for
those individuals unable to tackle these aversive events,
consecutive unpleasant episodes may lead to worse cog-
nitive performance later in life.
Data availability
The data that support the ﬁndings of this study are available from the
corresponding author upon reasonable request.
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